Target intelligence / Profile preview

Reward-related eating behavior

Molecular classification
Behavioral phenotype, Physiological process
01

Overview

Reward-related eating behavior, also known as hedonic eating, refers to the consumption of food driven by the brain's reward system rather than metabolic energy needs. This process is primarily mediated by the mesocorticolimbic dopamine pathway, which regulates the motivation or 'wanting' of food, and the endogenous opioid system, which influences the 'liking' or palatability of energy-dense foods [3, 6]. In modern environments where highly palatable, calorie-rich foods are abundant, reward-related signals can override homeostatic satiety cues, leading to overconsumption and weight gain [1, 4]. This behavior is a central feature in the pathophysiology of obesity, binge eating disorder, and food addiction [7, 8]. Pharmacological interventions targeting this behavior typically involve modulating neurotransmitter systems—such as dopamine, opioids, and GLP-1—to reduce food cravings, decrease the reinforcing properties of food, and improve inhibitory control over eating impulses [1, 11].

Other names
Hedonic eatingReward-induced eatingReward-based eating driveNon-homeostatic eatingPalatable food consumption
02

Mechanism of action

Pharmacological modulation of reward-related eating involves antagonizing opioid receptors to reduce food palatability, increasing synaptic dopamine/norepinephrine to reduce cravings and improve inhibitory control, or activating GLP-1 receptors to enhance satiety and dampen mesolimbic reward signaling [1, 3, 16].

03

Biological functions

Reward processingMotivation (Incentive salience)Hedonic impact (Liking)Energy homeostasisInhibitory control
04

Disease associations

ObesityBinge eating disorderFood addictionMetabolic syndromeBulimia nervosa
05

Safety considerations

Psychiatric adverse events (e.g., suicidal ideation, depression, anxiety)Gastrointestinal distress (e.g., nausea, vomiting)Potential for substance abuse or dependency (with stimulants)Cardiovascular risks (e.g., increased heart rate or blood pressure)Cognitive impairment (with certain anti-epileptics used off-label)
06

Interacting drugs

Naltrexone

7 more in the full profile.

07

Biomarkers

Yale Food Addiction Scale (YFAS) scoreReward-based Eating Drive (RED) scale scorefMRI BOLD signal in the ventral striatum/nucleus accumbensPlasma ghrelin levelsPower of Food Scale (PFS) scoreCortisol response to acute opioid blockade

Beyond the preview

Go deeper on Reward-related eating behavior.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Reward-related eating behavior.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call